These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15131756)

  • 21. Alterations in circulating angiogenic and anti-angiogenic factors in type 2 diabetic patients with neuropathy.
    Motawi TK; Rizk SM; Ibrahim IA; El-Emady YF
    Cell Biochem Funct; 2014 Mar; 32(2):155-63. PubMed ID: 23913471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromocriptine: a novel approach to the treatment of type 2 diabetes.
    Pijl H; Ohashi S; Matsuda M; Miyazaki Y; Mahankali A; Kumar V; Pipek R; Iozzo P; Lancaster JL; Cincotta AH; DeFronzo RA
    Diabetes Care; 2000 Aug; 23(8):1154-61. PubMed ID: 10937514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma ghrelin concentrations in different clinical stages of diabetic complications and glycemic control in Japanese diabetics.
    Ueno H; Shiiya T; Mizuta M; Mondal SM; Nakazato M
    Endocr J; 2007 Dec; 54(6):895-902. PubMed ID: 18025762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?
    Bonnefond A; Saulnier PJ; Stathopoulou MG; Grarup N; Ndiaye NC; Roussel R; Nezhad MA; Dechaume A; Lantieri O; Hercberg S; Lauritzen T; Balkau B; El-Sayed Moustafa JS; Hansen T; Pedersen O; Froguel P; Charpentier G; Marre M; Hadjadj S; Visvikis-Siest S
    PLoS One; 2013; 8(2):e55921. PubMed ID: 23405237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pan retinal photocoagulation on the serum levels of vascular endothelial growth factor in diabetic patients.
    Manaviat MR; Rashidi M; Afkhami-Ardekani M; Mohiti-Ardekani J; Bandala-Sanchez M
    Int Ophthalmol; 2011 Aug; 31(4):271-5. PubMed ID: 21647703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes: A cohort study.
    Zhang Q; Fang W; Ma L; Wang ZD; Yang YM; Lu YQ
    Medicine (Baltimore); 2018 Apr; 97(15):e0415. PubMed ID: 29642210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition.
    Chaturvedi N; Fuller JH; Pokras F; Rottiers R; Papazoglou N; Aiello LP;
    Diabet Med; 2001 Apr; 18(4):288-94. PubMed ID: 11437859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus.
    Demirtunc R; Duman D; Basar M; Bilgi M; Teomete M; Garip T
    J Diabetes Complications; 2009; 23(2):89-94. PubMed ID: 18358749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications.
    Bytzer P; Talley NJ; Hammer J; Young LJ; Jones MP; Horowitz M
    Am J Gastroenterol; 2002 Mar; 97(3):604-11. PubMed ID: 11922554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.
    Lim HS; Blann AD; Chong AY; Freestone B; Lip GY
    Diabetes Care; 2004 Dec; 27(12):2918-24. PubMed ID: 15562207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycemic control, lipid-lowering treatment, and prognosis in diabetic patients with peripheral atherosclerotic disease.
    Feringa HH; Karagiannis SE; Vidakovic R; Elhendy A; Schouten O; Boersma E; Bax JJ; Poldermans D
    Ann Vasc Surg; 2007 Nov; 21(6):780-9. PubMed ID: 17980797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycaemic control, markers of endothelial cell activation and oxidative stress in children with type 1 diabetes mellitus.
    Seckin D; Ilhan N; Ilhan N; Ertugrul S
    Diabetes Res Clin Pract; 2006 Aug; 73(2):191-7. PubMed ID: 16442660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation for fasting and 2-hour glucose and HbA1c for diagnosing diabetes based on prevalence of retinopathy in a Chinese population.
    Xin Z; Yuan MX; Li HX; Hua L; Feng JP; Shi J; Zhu XR; Cao X; Yang JK
    PLoS One; 2012; 7(7):e40610. PubMed ID: 22808204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients.
    Buraczynska M; Ksiazek P; Baranowicz-Gaszczyk I; Jozwiak L
    Nephrol Dial Transplant; 2007 Mar; 22(3):827-32. PubMed ID: 17121786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of glycemic variability and glycated hemoglobin as risk factors of coronary artery disease in patients with undiagnosed diabetes.
    Mi SH; Su G; Li Z; Yang HX; Zheng H; Tao H; Zhou Y; Tian L
    Chin Med J (Engl); 2012 Jan; 125(1):38-43. PubMed ID: 22340463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients.
    Davidson J; Koro C; Arondekar B; Lee BH; Fedder D
    Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus.
    Zorena K; Myśliwska J; Myśliwiec M; Rybarczyk-Kapturska K; Malinowska E; Wiśniewski P; Raczyńska K
    J Hum Hypertens; 2010 Nov; 24(11):755-62. PubMed ID: 20164848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
    Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
    Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.